BIFORTIF B.INFANTIS 35624 CLINICALLY STUDIED

Welcome to the Brand page for “BIFORTIF B.INFANTIS 35624 CLINICALLY STUDIED”, which is offered here for The mark consists of the stylised wording bifortif in blue and outlined in light blue within a white rectangle that is centered over two concentric circles both outlined in blue and having a yellow in the center and gray between the circles that contains the stylised wording b.infantis 35624 clinically studied.;dietetic food and substances adapted for medical use containing b.infantis 35624, reconstituted nutritional beverages containing cereals and/or proteins, cereal bars, powdered foods containing cereal and/or proteins; medicinal drinks containing b.infantis 35624; medicinal food supplements containing b.infantis 35624; health food supplements containing b.infantis 35624; dietary supplements containing b.infantis 35624; vitamin preparations containing b.infantis 35624; dietetic nutritive substances for medical use, containing b.infantis 35624, complete and incomplete nutritional beverages and powders for dietary management of a specific disease or condition; protein dietary supplements containing b.infantis 35624; vitamin and mineral supplements containing b.infantis 35624; mineral food supplements containing b.infantis 35624; dietetic yogurts adapted for medical use containing b.infantis 35624; food for babies containing b.infantis 35624; food supplements and medical food supplements, bacteriological cultures, bacteria and preparations of bacteria containing b.infantis 35624;the color(s) blue, light blue, gray, yellow and white is/are claimed as a feature of the mark.;b.infantis 35624 clinically studied;.

Its status is currently believed to be active. Its class is unavailable. “BIFORTIF B.INFANTIS 35624 CLINICALLY STUDIED” is believed to be currently owned by “PrecisionBiotics Group Limited”.